Protein Arginine Methyltransferase 5 as a negative epigenetic regulator of SRF/Myocardin-mediated contractile phenotype of Smooth Muscle Cell
PRMT5 ⏫H3R8me2 H3R4me2
SMC Prmt5 KO🐭; Lenti-shPRMT5; EPZ015666 (PRMT5i)▶️
⏬Neointima in injured carotid
#CardiovascRes 2023
academic.oup.com/cardiovascre...
PRMT5 ⏫H3R8me2 H3R4me2
SMC Prmt5 KO🐭; Lenti-shPRMT5; EPZ015666 (PRMT5i)▶️
⏬Neointima in injured carotid
#CardiovascRes 2023
academic.oup.com/cardiovascre...
July 3, 2026 at 11:05 AM
Protein Arginine Methyltransferase 5 as a negative epigenetic regulator of SRF/Myocardin-mediated contractile phenotype of Smooth Muscle Cell
PRMT5 ⏫H3R8me2 H3R4me2
SMC Prmt5 KO🐭; Lenti-shPRMT5; EPZ015666 (PRMT5i)▶️
⏬Neointima in injured carotid
#CardiovascRes 2023
academic.oup.com/cardiovascre...
PRMT5 ⏫H3R8me2 H3R4me2
SMC Prmt5 KO🐭; Lenti-shPRMT5; EPZ015666 (PRMT5i)▶️
⏬Neointima in injured carotid
#CardiovascRes 2023
academic.oup.com/cardiovascre...
MTAP loss has highest rates in ALK+ (up to 45%), followed by RET+ (up to 36%) and EGFR+ (up to 24%) NSCLC
IHC and NGS may be complementary for detection. #PRMT5i shows activity
PRMT5i + targeted therapy may outperform monotherapy in models
www.annalsofoncology.org/article/S092...
IHC and NGS may be complementary for detection. #PRMT5i shows activity
PRMT5i + targeted therapy may outperform monotherapy in models
www.annalsofoncology.org/article/S092...
MTAP Loss Is Frequent in Oncogene-Driven NSCLC and May Confer Sensitivity to Combined PRMT5 Inhibitors and Targeted Therapies
Homozygous loss of MTAP (methylthioadenosine phosphorylase) occurs in approximately
15% of cancers and leads to partial PRMT5 inhibition, creating a selective vulnerability
to PRMT5 inhibitors. The fr...
www.annalsofoncology.org
March 16, 2026 at 9:48 PM
MTAP loss has highest rates in ALK+ (up to 45%), followed by RET+ (up to 36%) and EGFR+ (up to 24%) NSCLC
IHC and NGS may be complementary for detection. #PRMT5i shows activity
PRMT5i + targeted therapy may outperform monotherapy in models
www.annalsofoncology.org/article/S092...
IHC and NGS may be complementary for detection. #PRMT5i shows activity
PRMT5i + targeted therapy may outperform monotherapy in models
www.annalsofoncology.org/article/S092...
Dr. @bcarneiro7 @BrownMedicine spoke about translational research initiatives, 9-ING-41, cytokines, MTAP deletion and PRMT5i, combos with PARPi, EMR tools, biobanks at 2025 @WIN_Consortium Symposium in collaboration with Advancing Precision Medicine @Dr_R_Kurzrock @AdvPrecMed
October 4, 2025 at 11:02 PM
Dr. @bcarneiro7 @BrownMedicine spoke about translational research initiatives, 9-ING-41, cytokines, MTAP deletion and PRMT5i, combos with PARPi, EMR tools, biobanks at 2025 @WIN_Consortium Symposium in collaboration with Advancing Precision Medicine @Dr_R_Kurzrock @AdvPrecMed